Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Net Income (2020 - 2025)

Historic Net Income for Bioventus (BVS) over the last 5 years, with Q3 2025 value amounting to $4.0 million.

  • Bioventus' Net Income changed N/A to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year change of. This contributed to the annual value of -$74.4 million for FY2023, which is 827.61% down from last year.
  • As of Q3 2025, Bioventus' Net Income stood at $4.0 million.
  • Bioventus' Net Income's 5-year high stood at $24.5 million during Q2 2021, with a 5-year trough of -$74.4 million in Q2 2023.
  • Over the past 4 years, Bioventus' median Net Income value was -$1.3 million (recorded in 2021), while the average stood at -$10.1 million.
  • As far as peak fluctuations go, Bioventus' Net Income surged by 13391.19% in 2021, and later crashed by 9348400.0% in 2022.
  • Bioventus' Net Income (Quarter) stood at -$25000.0 in 2021, then plummeted by 93484.0% to -$23.4 million in 2022, then plummeted by 218.13% to -$74.4 million in 2023, then surged by 105.38% to $4.0 million in 2025.
  • Its Net Income stands at $4.0 million for Q3 2025, versus $9.3 million for Q2 2025 and -$3.3 million for Q1 2025.